A randomized simulation trial evaluating ABiMed, a clinical decision support system for medication reviews and polypharmacy management

Abdelmalek Mouazer, Sophie Dubois, Romain Léguillon, Nada Boudegzdame, Thibaud Levrard, Yoann Le Bars, Christian Simon, Brigitte Séroussi, Julien Grosjean, Romain Lelong, Catherine Letord, Stéfan Darmoni, Karima Sedki, Pierre Meneton, Rosy Tsopra, Hector Falcoff, Jean-Baptiste Lamy·September 03, 2024

Summary

ABiMed, a clinical decision support system, significantly aids community pharmacists in medication reviews by identifying more drug-related problems and proposing better interventions without increasing time. It scores "excellent" for usability and enhances visual aspects and comparative treatment analysis. ABiMed improves problem identification, supports clinical interventions, and shows no difference in support based on pharmacist age or sex. It potentially validates its use in clinical conditions, focusing on polypharmacy management and STOPP/START rules.

Key findings

5

Advanced features